Acorda Therapeutics Cdt buy StockNews.com
Start price
31.05.23
/
50%
€0.58
Target price
31.05.24
-
Performance (%)
-18.97%
Price
02.06.23
€0.47
Summary
This prediction is currently active. The prediction for Acorda Therapeutics Cdt disappoints with a performance of -18.97%. This prediction currently runs until 31.05.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acorda Therapeutics Cdt | - | - |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
07.05.23
07.05.23
-
07.05.24
07.05.24
-22.31%
08.05.24
08.05.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24